InSphero's mission is to create a healthier society by enabling life science companies to bring more effective and safer drugs to market faster using its robust and physiologically relevant 3D InSightTM microtissue and organ-on-a-chip technology. The majority of world-class pharmaceutical companies are working with our 3D InSightTM Discovery Platforms including disease models for NAFLD/NASH and diabetes and with our market-leading solution for predictive liver toxicology. We strive to build long lasting partnerships based on our drug discovery and development platforms.
InSphero AG is headquartered in Schlieren, Switzerland, a biotech hub of Zurich. We are looking for a highly motivated individual to join our team as VP of Discovery Liver Disease (100%).
Reporting to the CEO, you run our Liver Discovery Group, focusing on industry partnerships for the development of treatments against NASH, NAFLD and other metabolic diseases. As an intrapreneur, you devote your energy to business development with global key accounts and cutting-edge R&D in 3D cell culture and organ-on-chip technology with a keen interest in human liver diseases. You lead an excellent team of experienced Scientists and Research Associates with a clear vision and drive the development of new products and services – from R&D, to IP, and market launch. To keep innovating, you acquire and execute publicly funded projects for liver disease modeling, present at international conferences, and build a global network of key-opinion leaders. The position offers a unique environment and opportunity to develop and commercialize disruptive solutions for drug discovery.
Starting date: as soon as possible.
We are looking forward receiving your application (resume, cover letter, diplomas, job references) by e-mail at email@example.com.